Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jocs.15731 http://scihub22266oqcxt.onion/10.1111/jocs.15731 34137079!8447084!34137079     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34137079.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Card+Surg 2021 ; 36 (9): 3217-3221 Nephropedia Template TP {{tp|p=34137079|t=2021. Prioritizing heart transplantation during the COVID-19 pandemic |pdf=|usr=}}{{34137079}} gab.com Text Prioritizing heart transplantation during the COVID-19 pandemic JO: J Card Surg http://www.kidney.de/pget.php?&tw=1&pmid=34137079 #FOAvip BACKGROUND: Coronavirus disease 2019 (COVID-19) has significantly impacted the healthcare landscape in the United States in a variety of ways including a nation-wide reduction in operative volume. The impact of COVID-19 on the availability of donor organs and the impact on solid organ transplant remains unclear. We examine the impact of COVID-19 on a single, large-volume heart transplant program. METHODS: A retrospective chart review was performed examining all adult heart transplants performed at a single institution between March 2020 and June 2020. This was compared to the same time frame in 2019. We examined incidence of primary graft dysfunction, continuous renal replacement therapy (CRRT) and 30-day survival. RESULTS: From March to June 2020, 43 orthotopic heart transplants were performed compared to 31 performed during 2019. Donor and recipient demographics demonstrated no differences. There was no difference in 30-day survival. There was a statistically significant difference in incidence of postoperative CRRT (9/31 vs. 3/43; p = .01). There was a statistically significant difference in race (23 W/8B/1AA vs. 30 W/13B; p = .029). CONCLUSION: We demonstrate that a single, large-volume transplant program was able to grow volume with little difference in donor variables and clinical outcomes following transplant. While multiple reasons are possible, most likely the reduction of volume at other programs allowed us to utilize organs to which we would not have previously had access. More significantly, our growth in volume was coupled with no instances of COVID-19 infection or transmission amongst patients or staff due to an aggressive testing and surveillance program. Twit Text FOAVip Prioritizing heart transplantation during the COVID-19 pandemic ????J Card Surg http://www.kidney.de/pget.php?&tw=1&pmid=34137079 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34137079 #FOAvip English Wikipedia <ref>{{Cite pmid|34137079}}</ref> Prioritizing heart transplantation during the COVID-19 pandemic #MMPMID34137079 Balsara KR; Rahaman Z; Sandhaus E; Hoffman J; Zalawadiya S; McMaster W; Lindenfeld J; Wigger M; Absi T; Brinkley DM; Menachem J; Punnoose L; Sacks S; Schlendorf K; Shah AS J Card Surg 2021[Sep]; 36 (9): 3217-3221 PMID34137079show ga BACKGROUND: Coronavirus disease 2019 (COVID-19) has significantly impacted the healthcare landscape in the United States in a variety of ways including a nation-wide reduction in operative volume. The impact of COVID-19 on the availability of donor organs and the impact on solid organ transplant remains unclear. We examine the impact of COVID-19 on a single, large-volume heart transplant program. METHODS: A retrospective chart review was performed examining all adult heart transplants performed at a single institution between March 2020 and June 2020. This was compared to the same time frame in 2019. We examined incidence of primary graft dysfunction, continuous renal replacement therapy (CRRT) and 30-day survival. RESULTS: From March to June 2020, 43 orthotopic heart transplants were performed compared to 31 performed during 2019. Donor and recipient demographics demonstrated no differences. There was no difference in 30-day survival. There was a statistically significant difference in incidence of postoperative CRRT (9/31 vs. 3/43; p = .01). There was a statistically significant difference in race (23 W/8B/1AA vs. 30 W/13B; p = .029). CONCLUSION: We demonstrate that a single, large-volume transplant program was able to grow volume with little difference in donor variables and clinical outcomes following transplant. While multiple reasons are possible, most likely the reduction of volume at other programs allowed us to utilize organs to which we would not have previously had access. More significantly, our growth in volume was coupled with no instances of COVID-19 infection or transmission amongst patients or staff due to an aggressive testing and surveillance program. |*COVID-19[MESH] |*Heart Transplantation[MESH] |*Tissue and Organ Procurement[MESH] |Adult[MESH] |Humans[MESH] |Pandemics[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH] |Tissue Donors[MESH]Prioritizing heart transplantation during the COVID-19 pandemic (epmc).pdf DeepDyve Pubget Overpricing